...
首页> 外文期刊>Cancer biology & therapy >Impaired CXCL4 expression in tumor-associated macrophages (TAMs) of ovarian cancers arising in endometriosis
【24h】

Impaired CXCL4 expression in tumor-associated macrophages (TAMs) of ovarian cancers arising in endometriosis

机译:子宫内膜异位症引起的卵巢癌肿瘤相关巨噬细胞(TAM)中CXCL4表达受损

获取原文
获取原文并翻译 | 示例
           

摘要

Inflammatory cells play important roles in progression of solid neoplasms including ovarian cancers. Tumor-associated macrophages (TAMs) contribute to angiogenesis and immune suppression by modulating microenvironment. Ovarian cancer develops occasionally on the bases of endometriosis, a chronic inflammatory disease. We have recently demonstrated differential expressions of CXCR3 variants in endometriosis and ovarian cancers. In this study, we showed impaired CXCL4 expression in TAMs of ovarian cancers arising in endometriosis. The expressions of CXCL4 and its variant CXCL4L1 were investigated among normal ovaries (n = 26), endometriosis (n = 18) and endometriosis-associated ovarian cancers (EA OCs) composed of clear cell (n = 13) and endometrioid (n = 11) types. In addition, four cases of EA OCs that contained both benign and cancer lesions contiguously in single cysts were investigated in the study. Western blot and quantitative RT-PCR analyses revealed significant downregulation of CXCL4 and CXCL4L1 in EA OCs compared with those in endometriosis. In all EA OCs coexisting with endometriosis in the single cyst, the expression levels of CXCL4 and CXCL4L1 were significantly lower in cancer lesions than in corresponding endometriosis. Histopathological study revealed that CXCL4 was strongly expressed in CD68 + infiltrating macrophages of endometriosis. In microscopically transitional zone between endometriosis and EA OC, CD68 + macrophages often demonstrated CXCL4- pattern. The majority of CD68 +TAMs in overt cancer lesions were negative for CXCL4. Collective data indicate that that CXCL4 insufficiency may be involved in specific inflammatory microenvironment of ovarian cancers arising in endometriosis. Suppression of CXCL4 in cancer lesions is likely to be attributable to TAMs in part.
机译:炎性细胞在包括卵巢癌在内的实体瘤的进展中起重要作用。肿瘤相关巨噬细胞(TAM)通过调节微环境促进血管生成和免疫抑制。卵巢癌偶尔会以子宫内膜异位症(一种慢性炎症性疾病)为基础发展。我们最近证明了子宫内膜异位症和卵巢癌中CXCR3变异体的差异表达。在这项研究中,我们显示子宫内膜异位症引起的卵巢癌TAM中CXCL4表达受损。研究了CXCL4及其变体CXCL4L1在正常卵巢(n = 26),子宫内膜异位(n = 18)和由透明细胞(n = 13)和子宫内膜样物质(n = 11)组成的与子宫内膜异位症相关的卵巢癌(EA OC)中的表达。 )类型。此外,研究中还研究了四例在单个囊肿中同时包含良性和癌性病变的EA OC。 Western blot和定量RT-PCR分析显示,与子宫内膜异位症相比,EA OC中CXCL4和CXCL4L1的显着下调。在单个囊肿中与子宫内膜异位症共存的所有EA OC中,癌症病变中CXCL4和CXCL4L1的表达水平明显低于相应的子宫内膜异位症。组织病理学研究表明,CXCL4在子宫内膜异位症的CD68 +浸润巨噬细胞中强烈表达。在子宫内膜异位症和EA OC之间的显微过渡区,CD68 +巨噬细胞通常表现出CXCL4-模式。明显的癌灶中大多数CD68 + TAM对CXCL4阴性。集体数据表明,CXCL4功能不全可能与子宫内膜异位症引起的卵巢癌特定的炎症微环境有关。癌症病变中CXCL4的抑制可能部分归因于TAM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号